Pereira_2002_J.Neurobiol_53_479

Reference

Title : Unconventional ligands and modulators of nicotinic receptors - Pereira_2002_J.Neurobiol_53_479
Author(s) : Pereira EF , Hilmas C , Santos MD , Alkondon M , Maelicke A , Albuquerque EX
Ref : Journal of Neurobiology , 53 :479 , 2002
Abstract : Evidence gathered from epidemiologic and behavioral studies have indicated that neuronal nicotinic receptors (nAChRs) are intimately involved in the pathogenesis of a number of neurologic disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. In the mammalian brain, neuronal nAChRs, in addition to mediating fast synaptic transmission, modulate fast synaptic transmission mediated by the major excitatory and inhibitory neurotransmitters glutamate and GABA, respectively. Of major interest, however, is the fact that the activity of the different subtypes of neuronal nAChR is also subject to modulation by substances of endogenous origin such as choline, the tryptophan metabolite kynurenic acid, neurosteroids, and beta-amyloid peptides and by exogenous substances, including the so-called nicotinic allosteric potentiating ligands, of which galantamine is the prototype, and psychotomimetic drugs such as phencyclidine and ketamine. The present article reviews and discusses the effects of unconventional ligands on nAChR activity and briefly describes the potential benefits of using some of these compounds in the treatment of neuropathologic conditions in which nAChR function/expression is known to be altered.
ESTHER : Pereira_2002_J.Neurobiol_53_479
PubMedSearch : Pereira_2002_J.Neurobiol_53_479
PubMedID: 12436414

Related information

Citations formats

Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX (2002)
Unconventional ligands and modulators of nicotinic receptors
Journal of Neurobiology 53 :479

Pereira EF, Hilmas C, Santos MD, Alkondon M, Maelicke A, Albuquerque EX (2002)
Journal of Neurobiology 53 :479